Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating an updated version of the study record. This change reflects an updated revision status on the page without altering the core content shown to users.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page displays a new Revision: v3.6.4, replacing the previous v3.6.3 tag. This indicates a minor version update of the page or its underlying system without changes to the study information.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, signaling a small site or document update rather than a content change.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page shows a revision update from v3.6.0 to v3.6.2, indicating a version update. It does not alter the study details or visible content.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded new help/navigation items (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and included the current recruitment status notice, while removing a variant label (Intervention / Treatment) and updating the revision tag to v3.6.0.SummaryDifference0.2%

- Check73 days agoChange DetectedA new bibliographic citation regarding a publication comparing dupilumab and upadacitinib has been added to the study record. The revision tag has been updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.